BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Staging
67 results:

  • 1. Incidental carcinoma of the prostate in cystoprostatectomy specimens - is it always a toothless lion?
    Dema V; Croitor A; Floruncuţ A; Dema S; Bardan TR; Tăban SM; Barna RA; Natarâş BR; Cumpănaş AA
    Rom J Morphol Embryol; 2023; 64(4):501-507. PubMed ID: 38184830
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Trends in disagreement with outside genitourinary pathology diagnoses at an academic center.
    Taylor C; Puzyrenko A; Iczkowski KA
    Pathol Res Pract; 2022 Aug; 236():153997. PubMed ID: 35780705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    De Man K; Van Laeken N; Schelfhout V; Fendler WP; Lambert B; Kersemans K; Piron S; Lumen N; Decaestecker K; Fonteyne V; Delrue L; De Vos F; Ost P
    Eur Urol; 2022 Nov; 82(5):501-509. PubMed ID: 35690515
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prevalence of sarcopenia in patients with solid tumors: A meta-analysis based on 81,814 patients.
    Surov A; Wienke A
    JPEN J Parenter Enteral Nutr; 2022 Nov; 46(8):1761-1768. PubMed ID: 35633306
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification and Validation of the Prognostic Impact of metastatic prostate cancer Phenotypes.
    Labe SA; Wang X; Lehrer EJ; Kishan AU; Spratt DE; Lin C; Morgans AK; Ponsky L; Garcia JA; Garrett S; Wang M; Zaorsky NG
    Clin Genitourin Cancer; 2022 Aug; 20(4):371-380. PubMed ID: 35383004
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    Yadav D; Hwang H; Qiao W; Upadhyay R; Chapin BF; Tang C; Aparicio A; Lopez-Olivo MA; Kang SK; Macapinlac HA; Bathala TK; Surasi DS
    Radiol Imaging Cancer; 2022 Mar; 4(2):e210091. PubMed ID: 35212559
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer.
    Orcajo-Rincon J; Muñoz-Langa J; Sepúlveda-Sánchez JM; Fernández-Pérez GC; Martínez M; Noriega-Álvarez E; Sanz-Viedma S; Vilanova JC; Luna A
    Clin Transl Oncol; 2022 Jul; 24(7):1290-1310. PubMed ID: 35152355
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of Lymphovascular Invasion on Overall Survival in Patients With prostate cancer Following Radical prostatectomy: Stage-per-Stage Analysis.
    Jamil M; Rakic N; Sood A; Keeley J; Modonutti D; Novara G; Jeong W; Menon M; Rogers CG; Abdollah F
    Clin Genitourin Cancer; 2021 Oct; 19(5):e319-e325. PubMed ID: 34154946
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in
    Nickols N; Anand A; Johnsson K; Brynolfsson J; Borreli P; Parikh N; Juarez J; Jafari L; Eiber M; Rettig M
    J Nucl Med; 2022 Feb; 63(2):233-239. PubMed ID: 34049980
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prediction of Pathologic Findings with MRI-Based Clinical staging Using the Bayesian Network Modeling in prostate cancer: A Radiation Oncologist Perspective.
    Wee CW; Jang BS; Kim JH; Jeong CW; Kwak C; Kim HH; Ku JH; Kim SH; Cho JY; Kim SY
    Cancer Res Treat; 2022 Jan; 54(1):234-244. PubMed ID: 34015891
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multiparametric MRI with in-bore targeted biopsy in the diagnostic pathway of prostate cancer: Data from a single institution experience.
    Nawfal G; Sarkis J; Assaf S; Mjaess G; Abi Chebel J; Semaan A; Alkassis M; Nemr E; Kamel G; Ayoub N; Sarkis P
    Urol Oncol; 2021 Nov; 39(11):781.e9-781.e15. PubMed ID: 33676850
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of prostate Specific Membrane Antigen PET/CT with
    Pienta KJ; Gorin MA; Rowe SP; Carroll PR; Pouliot F; Probst S; Saperstein L; Preston MA; Alva AS; Patnaik A; Durack JC; Stambler N; Lin T; Jensen J; Wong V; Siegel BA; Morris MJ
    J Urol; 2021 Jul; 206(1):52-61. PubMed ID: 33634707
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary lymph-node staging with
    Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
    Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Diagnosis and treatment of gastric cancer with immediate double primary carcinoma].
    Yao HB; Zhang RC; Hu JF; Zhao ZK; Shao QS
    Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(38):3001-3004. PubMed ID: 33086451
    [No Abstract]    [Full Text] [Related]  

  • 15. prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial staging of Treatment-naïve Intermediate- and High-risk prostate cancer: A Retrospective Single-center Study.
    Lenis AT; Pooli A; Lec PM; Sadun TY; Johnson DC; Lebacle C; Fendler WP; Eiber M; Czernin J; Reiter RE; Calais J
    Eur Urol Oncol; 2022 Oct; 5(5):544-552. PubMed ID: 32958451
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Incidental pulmonary embolism in oncologic patients-a systematic review and meta-analysis.
    Meyer HJ; Wienke A; Surov A
    Support Care Cancer; 2021 Mar; 29(3):1293-1302. PubMed ID: 32621266
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer.
    Fanti S; Goffin K; Hadaschik BA; Herrmann K; Maurer T; MacLennan S; Oprea-Lager DE; Oyen WJ; Rouvière O; Mottet N; Bjartell A
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):469-476. PubMed ID: 32617640
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging
    Chen MY; Franklin A; Yaxley J; Gianduzzo T; McBean R; Wong D; Tatkovic A; McEwan L; Walters J; Kua B
    BJU Int; 2020 Sep; 126(3):396-401. PubMed ID: 32592330
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Increased Frequency of Mesorectal and Perirectal LN Involvement in T4 prostate cancers.
    Abu-Gheida I; Bathala TK; Maldonado JA; Khan M; Anscher MS; Frank SJ; Choi S; Nguyen QN; Hoffman KE; McGuire SE; Kim M; Kuban DA; Aparicio A; Chapin BF; Tang C
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):982-985. PubMed ID: 32353391
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.